Oxford Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-378
Closed -$342K 387
2024
Q2
$342K Buy
+378
New +$302K 0.33% 111
2019
Q4
Sell
-67,448
Closed -$7.54M 1935
2019
Q3
$7.54M Sell
67,448
-23,528
-26% -$2.62M 0.18% 147
2019
Q2
$10.1M Buy
90,976
+77,714
+586% +$9.15M 0.22% 90
2019
Q1
$1.72M Sell
13,262
-43,874
-77% -$5.34M 0.04% 660
2018
Q4
$6.61M Sell
57,136
-51,486
-47% -$5.75M 0.17% 142
2018
Q3
$11.7M Buy
108,622
+17,625
+19% +$1.76M 0.24% 71
2018
Q2
$7.8M Buy
90,997
+39,196
+76% +$3.22M 0.15% 144
2018
Q1
$4.01M Sell
51,801
-34,935
-40% -$2.81M 0.08% 248
2017
Q4
$7.35M Sell
86,736
-12,793
-13% -$1.09M 0.16% 135
2017
Q3
$8.43M Sell
99,529
-14,786
-13% -$1.21M 0.16% 104
2017
Q2
$9.41M Buy
114,315
+86,516
+311% +$7.06M 0.19% 87
2017
Q1
$2.34M Buy
+27,799
New +$2.23M 0.06% 402

Other funds holding LLY

Oxford Asset Management's LLY Position: Q3 2024 in Review

Oxford Asset Management sold out of Eli Lilly (LLY) in Q3 2024, closing a stake of 378 shares — an estimated $342K sold.

Oxford Asset Management first reported a position in LLY in Q1 2017 and held it in 12 quarters. The position peaked at $11.7M in Q3 2018. 3,657 funds tracked by Wall St. Rank hold LLY as of Q3 2024.

  • Oxford Asset Management reported no remaining Eli Lilly position as of Q3 2024 after selling out during the quarter.
  • Oxford Asset Management sold 378 Eli Lilly shares in Q3 2024, an estimated $342K.
  • Oxford Asset Management first reported a position in Eli Lilly in Q1 2017 and held it in 12 quarters.
  • Oxford Asset Management's Eli Lilly position peaked at $11.7M in Q3 2018.
  • 3,657 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2024.

Based on Oxford Asset Management's 13F filing for Q3 2024, filed 14 Nov 2024.